Palantir shares slip despite posting record revenue in third quarter

Go back to Palantir shares slip despite posting record revenue in third quarter

Raymond James on Palantir (PLTR): 'was priced to perfection and valuation still sits at 85x 2026 sales'

November 4, 2025 11:49 AM EST

Raymond James analyst Brian Gesuale reiterated a Market Perform rating and {REMOVEPT} price target on Palantir Technologies Inc. (NASDAQ: PLTR).

The analyst comments "PLTR delivered a standout 3Q25 driven by record U.S. Commercial momentum, accelerating U.S. Government execution, and a sharp inflection in deal activity. Revenue of $1.181B (+63% y/y) topped consensus by ~10%, with adj.... More

Palantir Technologies Inc. (PLTR) PT Raised to $255 at BofA Securities

November 4, 2025 4:46 AM EST

BofA Securities analyst Mariana Perez Mora raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $255.00 (from $215.00) while maintaining a Buy rating.

The analyst comments "On the notion of real vs. fake AI we continue to expect growth would accelerate as more... More

Palantir Technologies Inc. (PLTR) PT Raised to $50 at RBC Capital, 'U.S. Strength Masks Structural Limits'

November 4, 2025 4:26 AM EST

RBC Capital analyst Rishi Jaluria raised the price target on Palantir Technologies Inc. (NASDAQ: PLTR) to $50.00 (from $45.00) while maintaining a Underperform rating.

The analyst comments "Palantir reported a strong quarter, with revenue growth of 63% YoY and R40 of 114%. Shares traded down ~4% AH. Results remain... More

Michael Burry's Scion Asset Management Updates 13F

November 3, 2025 4:54 PM EST

Michael Burry's Scion Asset Management Updates 13F

https://www.sec.gov/Archives/edgar/data/1649339/000164933925000007/xslForm13F_X02/infotable.xmlNotable:New Puts in Palantir (NASDAQ: PLTR) and NVIDIA (NASDAQ: NVDA). New Calls in Pfizer (NYSE: PFE) and Halliburton (NYSE: HAL).New Equity in Molina Healthcare (NYSE: MOH)
... More